Background: Patient-based symptom scores are the standard method for assessment in palliative care. There has been limited research on the frequency of errors upon using this approach. The Edmonton Symptom Assessment Scale (ESAS) is a reliable and valid assessment tool routinely used for symptom intensity assessment in our cancer center.
INTRODUCTION T
HE EDMONTON SYMPTOM ASSESSMENT SCALE (ESAS) is a 10-item patient-related symptom scale developed for use in assessing the symptoms of patients receiving palliative care. 1,2 A mapping of the patient's palliative needs forms the basis for the selection of questionnaires to assess the outcome of palliative care. 3 ESAS has been widely used in palliative care settings. 4 Be-cause of its brevity and ease of administration the ESAS has received much interest as a bedside clinical instrument. 5 The ESAS is a validated reliable instrument developed to measure different symptoms in palliative care patients. [5] [6] [7] [8] [9] However most tools validated in the research setting may behave differently once they are used regularly in the clinical setting.
The development of effective and consistent symptom assessment approach is critical for the provision of optimal care. 2, [5] [6] [7] We have noticed that patients may make errors when responding to items on the ESAS, as a result of misinterpreting the question. The purpose of this study was to understand the magnitude of this problem better and the effect of having a physician review the patient's answers with the patient.
It is important to find out if patients understand questions differently from what was intended and may answer them differently. 8 Since the scoring goes from 0-10 with 0 being absence of and 10 being the worst, patients may tend to score symptoms in the wrong way for some symptoms. For example a patient may have low appetite, well-being, and may not be sleeping well. Some patients tend to score these symptoms low without realizing that low scores would actually be interpreted as good appetite, well-being, and sleep by the physician. This can result in major changes in management in case if the nurse and the physician fail to ask questions to make sure if the patients are accurately representing on the ESAS about how they are doing.
METHODS

Sample
These were consecutive patients referred for symptom control and palliative care consultation (53 patients) or follow-up (7 patients) who were assessed regardless of their gender, age, ethnicity, or primary cancer. Patients were considered capable of completing forms in the view of the physician and the registered nurse.
Design
This study was done at the M. D. Anderson Outpatient Cancer Center in the department of Palliative Care. The charts of 60 patients were reviewed retrospectively. In this study, the same physician talked to all of the patients. The insti- Each patient rated his/her symptoms on the M. D Anderson assessment sheet on a 0-10 symptom assessment (ESAS) scale with 0 being no symptoms and 10 being the worst. The nurse transcribed this on the progress note. The physician (A.G.) looked at the ESAS done by the patient as part of his routine clinical practice, and immediately afterwards went to talk to the patient about his/her symptoms. The physician reviewed the symptom assessment scoring for each of the symptoms and checked whether the patients were correctly interpreting the ESAS scoring scale. For example, if a patient had scored appetite at 0/10, the physician asked if this meant that he/she had excellent appetite. The patient was then asked to give a revised score on the ESAS.
MEASUREMENTS AND STATISTICAL CONSIDERATIONS
Descriptive statistics were used to summarize patient characteristics such as gender, age, and type of cancer. A weighted statistic was used to determine agreement between the assessments of the patient before and after talking to the physician. For these analyses agreement was defined as both assessments rating in the same category of absent (0), mild (1-3), moderate (4-7), or severe (8) (9) (10) . In addition, we determined the screening performance of the ESAS for mild or moderate symptom assessment when considering the patients revised assessment as the gold standard by calculating sensitivity, specificity, and accuracy of the patients' initial assessments.
The following definitions were considered: Sensitivity of the patient's initial report: the percentage of persons with the symptom who were positive to the test. This was calculated as:
Specificity of the patient's initial report: the percentage of persons without the symptom who were negative to the test. This was calculated as:
Accuracy: the percentage of persons either having a positive test and the symptom present (ESAS symptom) or having a negative test and the symptom absent. This was calculated as follows:
True-positive ϩ True-negative True-positive ϩ False-positive ϫ 100 ϩ True negative ϩ False-negative A true-positive is when the patient's initial score correctly identified the symptom intensity. A false-negative is when the patient's initial score incorrectly missed identifying the symptom inTrue-negative ᎏᎏᎏᎏ True-negative ϩ False-positive tensity. A true-negative is when the patient's initial score correctly found that the symptom intensity was absent. A false-positive is when the patient's initial score incorrectly identified the symptom intensity as being present.
We reported the sensitivity, specificity, and accuracy of patient's initial ratings when using a cutoff in the ESAS of equal or more than 1 (mild or above) for each ESAS symptom and reported the sensitivity, specificity, and accuracy of patient's initial ratings when using a cutoff in the ESAS of equal or more than 4 (moderate or above) for each ESAS symptom.
RESULTS
Patients were evaluated for symptom scoring between February 2005 to June 2005. Table 1 summarizes patient characteristics. At the end of the study we had seen 60 consecutive patients with different primary cancers that included 33 males and 27 females. Of 60 patients seen, 53 were follow-up patients at the palliative care clinic and had previously received at least one ESAS evaluation and 7 were new consults who had not been previously exposed to ESAS. All patients were evaluable. The ESAS assessment tool is included in Appendix I. Table 2 shows that there was variable level of disagreement for most symptoms before and after the physician went in to talk to the patient. While the number of missing data was generally low the weighted for agreement ranged from 0.49 to 0.78. In total there were 540 symptoms evaluated in 60 patients. Two hundred sixty-three symptoms were scored at the same level by the SYMPTOM ASSESSMENT ERRORS 1061 patient (44%), 131 were revised downward (24%), and 146 were revised upward (27%). Table 3 shows the screening performance of patient self-assessment ESAS for detection of a symptom intensity of 1 of 10 or more. With the exception of nausea and drowsiness the self-completion showed high sensitivity for detection of symptoms when a threshold of 1 or more was used. The specificity was low for symptoms such as fatigue, drowsiness, lack of sleep, and appetite. The accuracy was maintained mostly because of the small number of false-positives for such symptoms. Table 4 shows screening performance of patients self-assessment ESAS for the detection of symptom intensity of 4 of 10 or more. With the exception of dyspnea, patients' self-reported ESAS had a sensitivity of less than 90% for detection of symptoms when a threshold of 4 of 10 or more was used. The specificity, although lower, was considerably improved for fatigue, appetite, and drowsiness but it remained low for sleep.
DISCUSSION
The ESAS is a simple, validated tool that is completed by the patient and allows for screening and monitoring for the most common symptoms in patients with advanced illness. [10] [11] [12] [13] [14] [15] Patient self-assessment of symptom severity provides clinicians and researchers with important information. It is crucial to evaluate the accuracy of a self-assessment questionnaire in the context of its intended use. 16 Questionnaire items might be misinterpreted by patients. 17 In our study, for pain, the disagreement between patients' assessments before and after the physician talked to the patients occurred because patients sometimes a Symptom score more than or equal to 4 with 0 ϭ no symptom, 10 ϭ worst symptom scale. ESAS, Edmonton Symptom Assessment Scale.
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rated their pain level at the time of the clinic visit or during a pain exacerbation instead of the intensity of pain during the last 24 hours as required by the ESAS. Sometimes patients might report pain levels that might only represent pain without taking pain medications. Failure to realize this difference could result in inappropriate pain management. A previous study by our group found poor levels of agreement in the 0-10 pain assessment routinely completed by patients in a inpatient medical ward as compared to assessment on same day by a palliative care advanced practice nurse or physician. 18 In 41 evaluable patients, sensitivity of the pain assessment was 45% for the diagnosis of moderate to severe pain. Unfortunately we did not check for the errors in the patient self-report that might explain the observed differences. Lower scores mean better symptom control 19 and higher scores mean poor symptom control. For symptoms of appetite and sleep the disagreement over the scoring occurred as patients sometimes scored them in a way, which was exactly opposite to the way they were feeling. The patients sometimes scored appetite and sleep low, thinking that low scores would reflect decreased appetite and sleep, failing to realize that these low scores would be interpreted as reflecting adequate sleep and appetite. Higher levels of disagreement were expected for the feeling of wellbeing as it was supposed to be scored in the same way as sleep and appetite. One reason for the observed high level of agreement may the large number of missing data (15% for well-being) possibly reflecting less understanding of the term "well-being" by the patients. The highest level of disagreement was observed for drowsiness. This was explained by some patients as interpreting more periods of napping during the day as drowsiness. One possibility is that the physician might have given subconscious cues to the patients to revise their estimate. However, our findings show that the number of upward revisions (24%) and downward revisions (27%) were not different.
Our study found that the initial patient self-assessment had low specificity for symptoms such as fatigue, drowsiness, appetite, and sleep (Table  3 ). This decrease was pronounced for symptom intensity greater than or equal to moderate with the exception of sleep (Table 4 ]. These findings suggest particular vigilance is required in the monitoring of mild symptoms with the exception of pain, depression, anxiety, and overall well-being.
In studies done by Jensen et al. 16, 24 and Groenvold et al. 8 for the validaton of questionnaires the agreement between the patient's and the observer's ratings was high. These studies compared self-assessment by patients with that of an independent observer after a clinical interview. Unfortunately these studies too did not report the number of errors or omissions made by patients in the process of completing the self-assessments that may have been collected in the process of data collection.
Other studies have compared patient self assessment with proxy ratings by physicians or nurses. 2, [20] [21] [22] [23] In these studies there were significant differences in rating but the investigator did not report on patient errors as a possible source for these differences.
Results of our previous studies of routine bedside pain assessment 18 and those of our current study with the patient's self-assessment using the ESAS suggest that there may be level of error when regular symptom assessment is conducted in clinical settings. Vigilance needs to be maintained during the interpretation of the ESAS scores. It is possible that patients approached for symptom research studies receive better coaching regarding how to complete symptom assessment scales compared to those regularly treated in the clinical setting. Future research should focus on ways to improve the comprehension by patients of the different scales. This may include audio-recorded instructions each time they complete the assessment, better use and location of anchoring terms (e.g., low scores for low appetite and high scores for high pain) and better definition of period of measurement (i.e., "during the last 24 hours," "right now," "worst symptom during the last 24 hours"). It is also possible that studies with larger samples might better characterize the types of errors and the patient factors that predispose to inaccurate answers (e.g., age, gender, and overall levels of patient distress).
Until more research is available our findings suggest that physicians should carry the ESAS symptom score into patients' rooms and review the results in order to ensure consistency.
Because symptom intensity assessment helps guide patient care, quality improvement, and epidemiologic research it is of utmost importance to minimize measurement errors in the clinical setting.
